Sylvia Herbrink
Centre Hospitalier de Luxembourg(LU)University of Luxembourg(LU)Luxembourg Institute of Health(LU)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Gut microbiota and health, RNA regulation and disease, Dementia and Cognitive Impairment Research, MicroRNA in disease regulation
Most-Cited Works
- → Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions(2020)221 cited
- → Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism(2024)25 cited
- → Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes(2022)25 cited
- → Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study(2023)24 cited
- → Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy(2024)13 cited
- → Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease(2025)4 cited
- → Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson’s disease over seven years in a cohort: a comparative analysis(2024)4 cited
- → Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease(2024)4 cited
- → Publisher Correction: Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes(2022)1 cited
- → Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease(2025)